Investment Summary |
|
|---|---|
| Date | 2006-01-01 |
| Target | SnagAJob |
| Sector | Internet Software and Services |
| Investor(s) | Adams Street Partners |
| Deal Type | Venture |
| Advisor(s) | Croft & Bender (Financial) |
SEARCH BY
| Category | Asset Manager |
|---|---|
| Founded | 1972 |
| PE ASSETS | 60.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Adams Street Partners is a diversified, global investment firm that targets direct, fund of funds, and secondary investments. Adams' direct investing group covers co-investments in buyout transactions, as well as growth equity and venture capital commitments. The direct buyout and growth equity team looks to commit $5 to $30 million per transaction. For venture related investments, commitments of $5 to $20 million are provided to companies in the technology, life sciences and technology enabled services sectors. Typically, target companies have received prior financing from early stage venture firms and are seeking additional capital to fund product development and commercialization. Adams Street Partners was formed in 1972 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 24 of 152 |
| Sector: Internet Software and Services M&A | 3 of 32 |
| Type: Venture M&A Deals | 15 of 102 |
| State: Virginia M&A | 2 of 6 |
| Country: United States M&A | 22 of 140 |
| Year: 2006 M&A | 1 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-11-01 |
Zalicus
Cambridge, Massachusetts, United States Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and inflammation. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-01-10 |
GlobeImmune
Louisville, Colorado, United States GlobeImmune is a biopharmaceutical company that focuses on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen platform. GlobeImmune was founded in 1995 and is headquartered in Louisville, Colorado. |
Buy | - |
